RxSight, Inc. (NASDAQ:RXST) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET
Company Participants
Oliver Moravcevic – VP, IR
Ron Kurtz – President and CEO
Shelley Thunen – CFO
Conference Call Participants
Lily Lozada – JPMorgan
Ryan Zimmerman – BTIG
Steve Lichtman – Oppenheimer
David Saxon – Needham
Lei Huang – Wells Fargo
Danielle Antalffy – UBS
Thomas Stephan – Stifel
Operator
Ladies and gentlemen, thank you for standing by. My name is Nasrin and I will be your conference operator today. At this time, I would like to welcome everyone to RxSight’s Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions]
I would now like to turn the conference over to Oliver Moravcevic, Vice President, Investor Relations. You may begin.
Oliver Moravcevic
Thank you, operator. Presenting today are RxSight President and Chief Executive Officer, Dr. Ron Kurtz; and Chief Financial Officer, Shelley Thunen. Earlier today, RxSight released financial results for the three months ended December 31, 2024. A copy of the press release is available on the company’s website.
Before we begin, I would like to inform you that comments and responses to questions during today’s call reflect management’s views as of today, February 25, 2025 and will include forward looking and opinion statements, including predictions, estimates, plans, expectations and other information.
Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are more fully described in our press release issued today and in our filings with the Securities and Exchange Commission or SEC. Our SEC filings can be found on our website or the SEC’s website. Investors are cautioned not to place undue reliance on forward-looking statements and we disclaim any obligation to update or revise these forward-looking statements except as may be required by law.
#RxSight #RXST #Earnings #Call #Transcript